Novexel is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2006.

When did Sofinnova Partners acquire Novexel?

Sofinnova Partners acquired Novexel in 2006 and exited after 4 years.

Has Novexel been sold?

Yes. Novexel was exited in 2010 via Trade Sale.

Biotech·

France·Exited 2010·Held 4yr

Novexel is a healthcare / biotech company, headquartered in France.

Entry

2006

Hold

4yr

Exit

2010

Est. EV

–

Investor

HQFrance

SectorHealthcare / Biotech

French specialty pharma developing novel beta-lactamase inhibitor antibiotics, acquired by AstraZeneca in 2010 for over $500 million.…Read full notes

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Capital VI

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member?

Data refreshed weekly · Sourced from public filings